These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 10199459)

  • 21. Long-term outcome in children with relapsed acute lymphoblastic leukemia after time-point and site-of-relapse stratification and intensified short-course multidrug chemotherapy: results of trial ALL-REZ BFM 90.
    Tallen G; Ratei R; Mann G; Kaspers G; Niggli F; Karachunsky A; Ebell W; Escherich G; Schrappe M; Klingebiel T; Fengler R; Henze G; von Stackelberg A
    J Clin Oncol; 2010 May; 28(14):2339-47. PubMed ID: 20385996
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of childhood acute lymphoblastic leukemia after the first relapse: curative strategies.
    Uderzo C; Dini G; Locatelli F; Miniero R; Tamaro P
    Haematologica; 2000 Nov; 85(11 Suppl):47-53. PubMed ID: 11268324
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relapse of acute lymphoblastic leukemia during pregnancy.
    Camera A; Campanile M; Catalano D; Mattace Raso A; Rotoli B
    Eur J Gynaecol Oncol; 1996; 17(4):303-5. PubMed ID: 8856312
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatocellular carcinoma: a rare late event in childhood acute lymphoblastic leukemia.
    Kumari TP; Shanvas A; Mathews A; Kusumakumary P
    J Pediatr Hematol Oncol; 2000; 22(3):289-90. PubMed ID: 10864067
    [No Abstract]   [Full Text] [Related]  

  • 25. Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000.
    Möricke A; Zimmermann M; Reiter A; Henze G; Schrauder A; Gadner H; Ludwig WD; Ritter J; Harbott J; Mann G; Klingebiel T; Zintl F; Niemeyer C; Kremens B; Niggli F; Niethammer D; Welte K; Stanulla M; Odenwald E; Riehm H; Schrappe M
    Leukemia; 2010 Feb; 24(2):265-84. PubMed ID: 20010625
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcome after first relapse in children with acute lymphoblastic leukemia: a report based on the Dutch Childhood Oncology Group (DCOG) relapse all 98 protocol.
    van den Berg H; de Groot-Kruseman HA; Damen-Korbijn CM; de Bont ES; Schouten-van Meeteren AY; Hoogerbrugge PM
    Pediatr Blood Cancer; 2011 Aug; 57(2):210-6. PubMed ID: 21337680
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Therapeutic strategies for childhood high-risk acute lymphoblastic leukemia].
    Lu XT
    Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Apr; 45(2):327-32. PubMed ID: 23591360
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Testicular relapse in acute lymphoblastic leukemia. The experience of a pediatrics service].
    Godinho C; Trindade AJ; Vale L; Coimbra E
    Acta Med Port; 1995 Nov; 8(11):613-8. PubMed ID: 8713506
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Asparaginase pharmacokinetics after intensive polyethylene glycol-conjugated L-asparaginase therapy for children with relapsed acute lymphoblastic leukemia.
    Hawkins DS; Park JR; Thomson BG; Felgenhauer JL; Holcenberg JS; Panosyan EH; Avramis VI
    Clin Cancer Res; 2004 Aug; 10(16):5335-41. PubMed ID: 15328169
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent research advances in childhood acute lymphoblastic leukemia.
    Pui CH
    J Formos Med Assoc; 2010 Nov; 109(11):777-87. PubMed ID: 21126650
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction failure in acute lymphoblastic leukemia of childhood.
    Silverman LB; Gelber RD; Young ML; Dalton VK; Barr RD; Sallan SE
    Cancer; 1999 Mar; 85(6):1395-404. PubMed ID: 10189148
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discontinuing chemoimmunotherapy in childhood acute lymphoblastic leukemia.
    Komada Y; Azuma E; Yamamoto H; Tanaka S; Shimizu K; Kamiya H; Sakurai M; Izawa T
    Biomed Pharmacother; 1988; 42(9):597-603. PubMed ID: 3240364
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Acute leukemia in childhood. Classification--diagnosis--therapy--prognosis].
    Creutzig U; Schrappe M
    Internist (Berl); 1996 Oct; 37(10):982-93. PubMed ID: 9019456
    [No Abstract]   [Full Text] [Related]  

  • 34. Treatment of childhood acute lymphoblastic leukemia in second remission with allogeneic bone marrow transplantation and chemotherapy: ten-year experience of the Italian Bone Marrow Transplantation Group and the Italian Pediatric Hematology Oncology Association.
    Uderzo C; Valsecchi MG; Bacigalupo A; Meloni G; Messina C; Polchi P; Di Girolamo G; Dini G; Miniero R; Locatelli F
    J Clin Oncol; 1995 Feb; 13(2):352-8. PubMed ID: 7844596
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isolated anterior chamber relapse in acute lymphoblastic leukemia.
    Naithani R; Agrawal N; Mahapatra M; Kumar R; Choudhary VP; Singh R; Sharma DN
    Ann Hematol; 2006 Dec; 85(12):889-91. PubMed ID: 16838162
    [No Abstract]   [Full Text] [Related]  

  • 36. Acute lymphoblastic leukaemia presenting as vasculitis.
    Gupta A; Al Alenezi H; Ibrahim JM; Marouf R
    Br J Haematol; 2006 Feb; 132(4):384. PubMed ID: 16412013
    [No Abstract]   [Full Text] [Related]  

  • 37. Poor outcome for children and adolescents with progressive disease or relapse of lymphoblastic lymphoma: a report from the berlin-frankfurt-muenster group.
    Burkhardt B; Reiter A; Landmann E; Lang P; Lassay L; Dickerhoff R; Lakomek M; Henze G; von Stackelberg A
    J Clin Oncol; 2009 Jul; 27(20):3363-9. PubMed ID: 19433688
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic cytogenetic markers in childhood acute lymphoblastic leukemia: cases from Mansoura Egypt.
    Settin A; Al Haggar M; Al Dosoky T; Al Baz R; Abdelrazik N; Fouda M; Aref S; Al-Tonbary Y
    Hematology; 2007 Apr; 12(2):103-11. PubMed ID: 17454190
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials.
    Attarbaschi A; Mann G; Panzer-Grümayer R; Röttgers S; Steiner M; König M; Csinady E; Dworzak MN; Seidel M; Janousek D; Möricke A; Reichelt C; Harbott J; Schrappe M; Gadner H; Haas OA
    J Clin Oncol; 2008 Jun; 26(18):3046-50. PubMed ID: 18565891
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Childhood leukemia from the perspective of 15 years of its intensive treatment].
    Radwańska U
    Pediatr Pol; 1988 Nov; 63(11):689-92. PubMed ID: 3253654
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.